https://www.unibestcn.com/en 2026-07-31T08:38:45.769Z weekly 1 https://www.unibestcn.com/zh 2026-07-31T08:38:45.769Z weekly 1 https://www.unibestcn.com/en/solutions 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/zh/solutions 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/en/solutions/fso 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/zh/solutions/fso 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/en/solutions/fso-plus 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/zh/solutions/fso-plus 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/en/solutions/api-intermediate-supply 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/zh/solutions/api-intermediate-supply 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/en/solutions/technology-transfer 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/zh/solutions/technology-transfer 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/en/solutions/regulatory-quality-support 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/zh/solutions/regulatory-quality-support 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/en/solutions/supply-chain-risk-management 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/zh/solutions/supply-chain-risk-management 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/en/solutions/case-studies 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/zh/solutions/case-studies 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/en/capabilities 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/zh/capabilities 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/en/capabilities/ai-intelligence 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/zh/capabilities/ai-intelligence 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/en/capabilities/global-registration 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/zh/capabilities/global-registration 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/en/capabilities/hta-assessment 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/zh/capabilities/hta-assessment 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/en/submit-project 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/zh/submit-project 2026-07-31T08:38:45.769Z monthly 0.9 https://www.unibestcn.com/en/about 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/about 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/products 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/products 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/products/pharmaceutical-ingredients 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/products/pharmaceutical-ingredients 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/products/biological-ingredients 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/products/biological-ingredients 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/licensing 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/licensing 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/licensing/new-drug-candidates 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/licensing/new-drug-candidates 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/licensing/finished-dosage-form 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/licensing/finished-dosage-form 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/licensing/new-drug-candidates-list 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/licensing/new-drug-candidates-list 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/licensing/finished-dosage-form-list 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/licensing/finished-dosage-form-list 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/resources 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/resources 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/why-us 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/why-us 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/news/company 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/news/company 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/news/industry 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/news/industry 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/contact 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/contact 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/join-us 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/join-us 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/news/industry/page/2 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/news/industry/page/2 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/news/industry/page/3 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/news/industry/page/3 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/news/industry/page/4 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/zh/news/industry/page/4 2026-07-31T08:38:45.769Z monthly 0.8 https://www.unibestcn.com/en/news/eli-lilly-ataibeckley-psychedelics-acquisition-2-8b-2026 2026-07-17T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/eli-lilly-ataibeckley-psychedelics-acquisition-2-8b-2026 2026-07-17T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/merck-lipfrendra-oral-pcsk9-cholesterol-pill-fda-approval-2026 2026-07-17T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/merck-lipfrendra-oral-pcsk9-cholesterol-pill-fda-approval-2026 2026-07-17T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/merck-sac-tmt-lung-cancer-chemo-replacement-2026 2026-07-16T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/merck-sac-tmt-lung-cancer-chemo-replacement-2026 2026-07-16T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/celcuity-fda-approval-breast-cancer-revtorpyk-2026 2026-07-16T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/celcuity-fda-approval-breast-cancer-revtorpyk-2026 2026-07-16T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/biogen-biib080-tau-alzheimers-celia-trial-2026 2026-07-15T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/biogen-biib080-tau-alzheimers-celia-trial-2026 2026-07-15T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/avere-hansoh-il23-psoriasis-pill-licensing-2026 2026-07-15T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/avere-hansoh-il23-psoriasis-pill-licensing-2026 2026-07-15T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/revolution-medicines-daraxonrasib-pancreatic-cancer-breakthrough-2026 2026-07-14T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/revolution-medicines-daraxonrasib-pancreatic-cancer-breakthrough-2026 2026-07-14T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/gsk-terminates-alector-neuroscience-deal-2-2b-2026 2026-07-14T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/gsk-terminates-alector-neuroscience-deal-2-2b-2026 2026-07-14T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/gsk-hansoh-b7h3-adc-lung-cancer-phase3-2026 2026-07-13T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/gsk-hansoh-b7h3-adc-lung-cancer-phase3-2026 2026-07-13T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/arpa-h-160m-custom-gene-editing-rare-disease-2026 2026-07-13T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/arpa-h-160m-custom-gene-editing-rare-disease-2026 2026-07-13T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/roche-ionis-huntingtons-drug-development-halted-2026 2026-07-10T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/roche-ionis-huntingtons-drug-development-halted-2026 2026-07-10T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/astrazeneca-ionis-eplontersen-heart-failure-2026 2026-07-10T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/astrazeneca-ionis-eplontersen-heart-failure-2026 2026-07-10T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/astrazeneca-gsk-sino-biopharm-china-respiratory-deals-2026 2026-07-08T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/astrazeneca-gsk-sino-biopharm-china-respiratory-deals-2026 2026-07-08T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/oberland-capital-meiragtx-gene-therapy-eye-diseases-400m-2026 2026-07-08T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/oberland-capital-meiragtx-gene-therapy-eye-diseases-400m-2026 2026-07-08T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/vera-therapeutics-trutakna-iga-nephropathy-approval-2026 2026-07-07T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/vera-therapeutics-trutakna-iga-nephropathy-approval-2026 2026-07-07T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/kailera-hrs7535-obesity-pill-china-phase3-2026 2026-07-07T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/kailera-hrs7535-obesity-pill-china-phase3-2026 2026-07-07T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/vertex-crinetics-endocrinology-acquisition-2026 2026-07-07T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/vertex-crinetics-endocrinology-acquisition-2026 2026-07-07T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/novartis-myricx-adc-acquisition-2026 2026-07-07T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/novartis-myricx-adc-acquisition-2026 2026-07-07T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/viridian-lumvoa-thyroid-eye-disease-approval-2026 2026-07-06T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/viridian-lumvoa-thyroid-eye-disease-approval-2026 2026-07-06T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/fda-q3-2026-decisions-watchlist 2026-07-06T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/fda-q3-2026-decisions-watchlist 2026-07-06T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/celea-puretech-ipf-drug-180m-funding-2026 2026-07-03T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/celea-puretech-ipf-drug-180m-funding-2026 2026-07-03T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/roche-kras-divarasib-lung-cancer-phase3-2026 2026-07-03T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/roche-kras-divarasib-lung-cancer-phase3-2026 2026-07-03T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/ipsen-memo-therapeutics-800m-rare-disease-2026 2026-07-02T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/ipsen-memo-therapeutics-800m-rare-disease-2026 2026-07-02T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/fda-genzyme-irish-site-warning-letter-2026 2026-07-02T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/fda-genzyme-irish-site-warning-letter-2026 2026-07-02T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/anthropic-enters-pharmaceutical-drug-development-2026 2026-07-01T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/anthropic-enters-pharmaceutical-drug-development-2026 2026-07-01T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/theravance-zymeworks-929m-buyout-clinical-setbacks-2026 2026-07-01T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/theravance-zymeworks-929m-buyout-clinical-setbacks-2026 2026-07-01T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/ipsen-kartos-therapeutics-blood-cancer-acquisition-2026 2026-06-30T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/ipsen-kartos-therapeutics-blood-cancer-acquisition-2026 2026-06-30T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/sobi-crl-gout-drug-manufacturing-2026 2026-06-30T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/sobi-crl-gout-drug-manufacturing-2026 2026-06-30T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/bio-2026-us-china-biotech-regulation 2026-06-29T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/bio-2026-us-china-biotech-regulation 2026-06-29T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/ionis-tryngolza-fda-broader-label-2026 2026-06-29T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/ionis-tryngolza-fda-broader-label-2026 2026-06-29T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/biogen-apellis-pipeline-rationalization-2026 2026-06-26T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/biogen-apellis-pipeline-rationalization-2026 2026-06-26T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/merck-kgaa-bio-techne-acquisition-2026 2026-06-26T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/merck-kgaa-bio-techne-acquisition-2026 2026-06-26T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/novartis-antares-small-molecule-pact-2026 2026-06-25T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/novartis-antares-small-molecule-pact-2026 2026-06-25T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/hhs-fast-track-drug-research-china-2026 2026-06-25T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/hhs-fast-track-drug-research-china-2026 2026-06-25T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/unibest-fdf-pipeline-2025 2025-07-02T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/unibest-fdf-pipeline-2025 2025-07-02T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/unibest-newco-licensing-pipeline-july 2025-07-01T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/unibest-newco-licensing-pipeline-july 2025-07-01T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/global-pharma-licensing-trends-2025 2025-06-30T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/global-pharma-licensing-trends-2025 2025-06-30T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/en/news/kv13-target-global-collaboration 2025-06-20T00:00:00.000Z monthly 0.6 https://www.unibestcn.com/zh/news/kv13-target-global-collaboration 2025-06-20T00:00:00.000Z monthly 0.6